Continuous treatment with recombinant Mycobacterium tuberculosis CFP-10-ESAT-6 protein activated human monocyte while deactivated LPS-stimulated macrophage

Biochemical and Biophysical Research Communications

Volumn 365, Issue 3, 2008, Pages 534-540

  Feng, Yonghong ^a   Yang, Xin ^b   Liu, Zhonghua ^a   Liu, Yaoting ^a   Su, Bo ^a   Ding, Yuansheng ^a   Qin, Lianhua ^a   Yang, Hua ^a   Zheng, Ruijuan ^a   Hu, Zhongyi ^a  

^a TONGJI UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

CFP 10 ESAT 6 complex; Macrophage; Mycobacterium tuberculosis; THP 1 cells; TNF

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CULTURE FILTERED PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENZYME INACTIVATION; ENZYME INHIBITION; HLA SYSTEM; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 36549012144     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.022     Document Type: Article

References (31)

1. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., and Smal P.M. Comparative genomics of BCG vaccines by whole genome DNA microarray. Science 284 (1999) 1520-1523
2. Gordon S.V., Brosch R., Billault A., Garnier T., Eiglmeier K., and Cole S.T. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 32 (1999) 643-655
3. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., and Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189 (1999) 1973-1980
4. Wards B.J., de Lisle G.W., and Collins D.M. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Tuber. Lung Dis. 80 (2000) 185-189
5. Pym A.S., Brodin P., Brosch R., Huerre M., and Cole S.T. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46 (2002) 709-717
6. Lewis K.N., Liao R., Guinn K.M., Hickey M.J., Smith S., Behr M.A., and Sherman D.R. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J. Infect. Dis. 187 (2003) 117-123
7. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., Griffiths K.E., Marchal G., Leclerc C., and Cole S.T. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9 (2003) 533-539
8. Brodin P., Rosenkrands I., Andersen P., Cole S.T., and Brosch R. ESAT-6 proteins: protective antigens and virulence factors?. Trends Microbiol. 12 (2004) 500-508
9. Pollock J.M., and Andersen P. Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect. Immun. 65 (1997) 2587-2592
10. Skjot R.L., Oettinger T., Rosenkrands I., Ravn P., Brock I., Jacobsen S., and Andersen P. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect. Immun. 68 (2000) 214-220
11. Renshaw P.S., Panagiotidou P., Whelan A., Gordon S.V., Hewinson R.G., Williamson R.A., and Carr M.D. Conclusive Evidence That the Major T-cell Antigens of the Mycobacterium tuberculosis Complex ESAT-6 and CFP-10 Form a Tight, 1:1 Complex and Characterization of the Structural Properties of ESAT-6, CFP-10, and the ESAT-6-CFP-10 Complex: implications for pathogenesis and virulence. J. Biol. Chem. 277 (2002) 21598-21603
12. Latchumanan V.K., Singh B., Sharma P., and Natarajan K. Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. J. Immunol. 169 (2002) 6856-6864
13. Trajkovic V., Singh G., Singh B., Singh S., and Sharma P. Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor-α and nitric oxide. Infect. Immun. 70 (2000) 6558-6566
14. Maue A.C., Waters W.R., Davis W.C., Palmer M.V., Minion F.C., and Estes D.M. Analysis of immune responses directed toward a recombinant early secretory antigenic target six-kilodalton protein-culture filtrate protein 10 fusion protein in Mycobacterium bovis-infected cattle. Infect. Immun. 73 (2005) 6659-6667
15. Zheng L., He M., Long M., Blomgran R., and Stendahl O. Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages. J. Immunol. 173 (2004) 6319-6326
16. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schreiber R., Mak T.W., and Bloom B.R. Tumour necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2 (1995) 561-572
17. Zganiacz A., Santosuosso M., Wang J., Yang T., Chen L., Anzulovic M., Alexander S., Gicquel B., Wan Y., Bramson J., Inman M., and Xing Z. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113 (2004) 401-413
18. Caruso A.M., Serbina N., Klein E., Triebold K., Bloom B.R., and Flynn J.L. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162 (1999) 5407-5416
19. Cheadle E.J., Selby P.J., and Jackson A.M. Mycobacterium bovis bacillus Calmette-Guerin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism. Immunology 108 (2003) 79-88
20. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., and Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
21. Oswald I.P., Dozois C.M., Fournout S., Petit J.F., and Lemaire G. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate. Eur. Cytokine Netw. 10 (1999) 533-540
22. Brusasca P.N., Colangeli R., Lyashchenko K.P., Zhao X., Vogelstein M., Spencer J.S., McMurray D.N., and Gennaro M.L. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand. J. Immunol. 54 (2001) 448-452
23. Beatty W.L., and Russel D.G. Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infect. Immun. 68 (2000) 6997
24. Singh G., Singh B., Trajkovic V., and Sharma P. Mycobacterium tuberculosis 6 kDa early secreted antigenic target stimulates activation of J774 macrophages. Immunol. Lett. 98 (2005) 180-188
25. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
26. Tsang F., Koh A.H., Ting W.L., Wong P.T., and Wong W.S. Effects of mitogen-activated protein kinase kinase inhibitor PD 98059 on antigen challenge of guinea-pig airways in vitro. Br. J. Pharmacol. 125 (1998) 61-68
27. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
28. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., and Fukami Y. Genistein, a specific inhibitor of tyrosinespecific protein kinases. J. Biol. Chem. 262 (1987) 5592-5595
29. Sherry C.L., O'Connor J.C., Krame J.M., and Freund G.G. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J. Immunol. 178 (2007) 663-670
30. Lombardo E., Alvarez-Barrientos A., Maroto B., Bosca L., and Knaus U.G. TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signaling. J. Immunol. 178 (2007) 3731-3739
31. Pathak S.K., Basu S., Basu K.K., Banerjee A., Pathak S., Bhattacharyya A., Kaisho T., Kundu M., and Basu J. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat. Immunol. 8 (2007) 610-618